Venus Remedies Limited developed its global reach with the introduction of Elores in Ecuador
Friday, 13 October 2023, 11:01 IST
Venus Remedies Limited, a renowned pharmaceutical company known for its innovation and commitment to healthcare quality, is pleased to announce the successful introduction of Elores in Ecuador.
This huge expansion follows prior Elores debuts in Saudi Arabia, Myanmar, Oman, Tanzania, Ethiopia, and India and represents a watershed point in the company's worldwide expansion. Furthermore, the dossier has been presented in around 15 countries in order to get marketing authorizations.
Elores, a cutting-edge antibiotic formulation, has been established to combat multi-drug-resistant infections, making it an innovative addition to Venus Remedies Limited‘s product portfolio. It is a novel patented Antibiotic Adjuvant Entity containing a beta-lactam antibiotic.
A beta-lactamase inhibitor and an Antibiotic Resistance Breaker (ARB) operate synergistically to recover antibiotic activity and suppress the emergence of resistance against the antibiotic. With its proven efficacy toward a wide range of bacteria, Elores is set to revolutionize the treatment of infections and enhance the quality of healthcare in Ecuador.
This huge expansion follows prior Elores debuts in Saudi Arabia, Myanmar, Oman, Tanzania, Ethiopia, and India and represents a watershed point in the company's worldwide expansion. Furthermore, the dossier has been presented in around 15 countries in order to get marketing authorizations.
Elores, a cutting-edge antibiotic formulation, has been established to combat multi-drug-resistant infections, making it an innovative addition to Venus Remedies Limited‘s product portfolio. It is a novel patented Antibiotic Adjuvant Entity containing a beta-lactam antibiotic.
A beta-lactamase inhibitor and an Antibiotic Resistance Breaker (ARB) operate synergistically to recover antibiotic activity and suppress the emergence of resistance against the antibiotic. With its proven efficacy toward a wide range of bacteria, Elores is set to revolutionize the treatment of infections and enhance the quality of healthcare in Ecuador.
